Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE3
A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2 Trial of ADI-270 in ccRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
- Status
- RECRUITING
- Phase
- PHASE1
Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2